Bulletin
Investor Alert

London Markets Close in:

Company Close Updates Archives | Email alerts

April 19, 2021, 4:31 p.m. EDT

Moderna Inc. stock falls Monday, underperforms market

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

MarketWatch Automation

Shares of Moderna Inc. MRNA slipped 5.21% to $161.91 Monday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index COMP falling 0.98% to 13,914.77 and Dow Jones Industrial Average DJIA falling 0.36% to 34,077.63. Moderna Inc. closed $27.35 short of its 52-week high ($189.26), which the company reached on February 8th.

The stock underperformed when compared to some of its competitors Monday, as AbbVie Inc. ABBV rose 0.65% to $108.61, Amgen Inc. AMGN rose 0.10% to $255.97, and AstraZeneca PLC ADR AZN rose 1.75% to $51.63. Trading volume (9.1 M) eclipsed its 50-day average volume of 9.0 M.

Editor's Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.

Get news alerts on Moderna Inc. — or create your own.
This Story has 0 Comments
Be the first to comment
More News In
Markets

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.